TRPM3 activity is impaired in chronic fatigue syndrome/myalgic encephalomyelitis patients suggesting changes in intracellular Ca2+ concentration, which may impact natural killer cellular functions [http://www.ncbi.nlm.nih.gov/pubmed/30134818?dopt=AbstractPlus]. Here, TRPM3 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.